Description
· Data Bridge Market Research analyses that the dermatology drugs market is expected to grow at a CAGR of 8.2% during the forecast period. The “prescription based drugs” accounts for the largest prescription mode segment in the dermatology drugs market within the forecasted period.
Market Analysis and Size
The market was particularly hard hit during the 2008-2009 recession, due to its reliance on disposable consumer income. However, the dermatology drugs industry quickly recovered in the following years owing to the rising expenditure for the skin care which increased the pace of expansion. In recent years, the market for dermatology drugs has seen significant growth and the growth is expected to grow at the same pace within the forecasted period.
Dermatology drugs are basically the drugs that are used to treat several skin conditions. The dermatological indications such as pigmentation, acne, wrinkles, psoriasis and many other can be treated by the dermatology drugs.
Drivers
· Surging Prevalence Of Skin Diseases
The high frequency of skin cancer and other skin disorders or other skin issues such as acne, vitiligo and dermatosis coupled with demand of effective drugs are the most significant factor driving the growth for this market. Moreover, the effective surgical treatments are available for common dermatology conditions and the inexpensive nature and easy availability of these drugs are also projected to boost the growth of the market.
Moreover, the rise in number of companies investing in the market and a significant increase in the number of drug classes available are also expected to fuel market growth. The increased awareness among patients regarding available courses of treatment for dermatological conditions and rising expenditure on skin and haircare products also cushions the market’s growth within the forecasted period.
Opportunities
Furthermore, the plausible pace of research and development practices from major industry players extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Moreover, the expansion of the number of indications treated by topical drugs and growing awareness regarding the dermatological procedures will further expand the dermatology drugs market's growth rate in the future.
Restraints/Challenges
On the other hand, the patient non-adherence to treatment along with the high costs associated with drugs is expected to obstruct market growth. Also, the dearth of knowledge procedure and are projected to challenge the dermatology drugs market in the forecast period of 2022-2029.
This dermatology drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the dermatology drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Competitive Landscape and Dermatology Drugs Market Share Analysis
The dermatology drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to dermatology drugs market.
Some of the major players operating in the dermatology drugs market are
· Novartis AG,
· Pfizer Inc.,
· Eli Lilly and Company.,
· Johnson & Johnson Services, Inc.,
· Almirall, S.A,
· Mylan N.V.,
· Sun Pharmaceutical Industries Ltd.,
· UCB S.A.,
· Glenmark Pharmaceuticals Limited,
· Tolmar Pharmaceuticals, Inc.,
· GlaxoSmithKline plc.,
· Galderma Laboratories, L.P.,
· Teva Pharmaceutical Industries Ltd.,
· LEO Pharma A/S,
· MELINTA THERAPEUTICS, INC.,
· Mayne Pharma Group Limited,
· BIOFRONTERA AG, and AbbVie Inc., among others.
Scope of the U.S. Dermatology Drug Market
All country based analysis of the U.S. dermatology drugs market is further analyzed based on maximum granularity into further segmentation. On the basis of drug class, the market is segmented into corticosteroids, retinoids, monoclonal antibodies, antibiotics agent, antiviral agents, antifungal drugs, antihistamines agents, immunosuppressive drugs and others. On the basis of drug type, the market is segmented into branded and generics. On the basis of prescription mode, the market is segmented into prescription based drugs and over-the-counter drugs. On the basis of indication, the market is segmented into infectious skin disease, inflammatory/autoimmune disorders, pigmentation disorders, skin cancer and others. On the basis of route of administration, the market is segmented into oral, topical and parenteral. On the basis of end user, the market is segmented into homecare, hospitals, dermatalogy clinics and others. On the basis of distribution channel, the market is segmented into retail pharmacy, hospitals pharmacy, online pharmacy and others.
Major TOC of the U.S. Dermatology Drugs Market Report
Chapter One:
· MARKET SEGEMENTATION
· EXECUTIVE SUMMARY
· PREMIUM INSIGHTS
· MARKET OVERVIEW
Get TOC of the Report: https://www.databridgemarketresearch.com/toc/?dbmr=us-dermatology-drugs-market
Research Methodology : U.S. Dermatology Drugs Market
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Access Full Report:- https://www.databridgemarketresearch.com/reports/us-dermatology-drugs-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse Related Reports@
